crossover
    2017
    High Quality

    Mucuna pruriens in Parkinson disease: a double-blind, randomized, controlled, crossover study

    Cilia R, Laguna J, Cassani E

    Published in Neurology

    Key Findings

    Mucuna pruriens powder produced motor benefit comparable to levodopa/benserazide with fewer dyskinesias in the short term.

    Conclusions

    Effective levodopa source in resource-limited settings.

    Limitations

    Single-dose challenge design.

    Supplements Studied

    Mucuna pruriens produced motor benefit comparable to levodopa/benserazide with fewer dyskinesias in the short term.

    Outcomes Measured

    Dopamine Optimization

    Mucuna delivers natural levodopa producing dopaminergic motor benefit comparable to pharmaceutical levodopa.

    Related Health Concerns

    Parkinson's Disease

    Study Details

    Year:2017
    Sample Size:18
    Duration:1 weeks
    Quality Score:7/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.